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ABSTRACT
The distal end of mouse chromosome 1 (Chr 1) harbors quantitative trait loci (QTLs) that regulate bone mineral density (BMD) and share
conserved synteny with human chromosome 1q. The objective of this article was to map this mouse distal Chr 1 region and identify
gene(s) responsible for BMD regulation in females. We used X-ray densitometry [ie, dual-energy X-ray Absorptiometry (DXA), micro–
computed tomography (mCT),and peripheral quantitative computed tomography (pQCT)] to phenotype asetof nestedcongenic strains
constructed from C57BL/6BmJ (B6/Bm) and C3H/HeJ (C3H) mice to map the region associated with the BMD QTL. The critical region has
been reduced to an interval of 0.152 Mb that contributes to increased BMD when C3H alleles are present. Histomorphometry and
osteoblast cultures indicated that increased osteoblast activity was associated with increased BMD in mouse strains with C3H alleles in
thiscriticalregion.Thisregioncontainstwogenes,Aim2,whichbindswithcytoplasmicdsDNAandresultsinapoptosis,andAC084073.22,
a predicted gene of unknown function. Ovariectomy induced bone loss in the B6/Bm progenitor and the three congenic strains
regardless of the alleles present in the critical BMD region. High dietary fat treatment (thought to suppress distal Chr 1 QTL for BMD in
mice) did not induce bone loss in the congenics carrying C3H alleles in the critical 0.152Mb carrying the AIM2 and AC084073.22 genes.
GeneexpressionstudiesinwholeboneofkeycongenicsshoweddifferentialexpressionofAC084073.22forstrainscarryingB6/Bmversus
C3HallelesbutnotforAim2.Inconclusion,ourdatasuggestthatosteoblastsarethecellulartargetofgeneactionandthatAC084073.22is
the best candidate for female BMD regulation in the distal region of mouse Chr 1.  2011 American Society for Bone and Mineral
Research.
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Introduction
T
here is general recognition that skeletal traits are both
environmentally and genetically complex. The genetic basis
of osteoporosis results from alterations in many genes that
individually make small contributions. The search for genes that
contribute to the pathogenesis of osteoporosis has intensified as
aging populations expand worldwide. Enhancing that search has
been remarkable growth in knowledge of bone biology over the
past two decades and equally remarkable advancements in
techniques and analytical methods within the genetics field.
Over the past decade, investigations aimed at finding
osteoporosis-related genes have adopted the genome-wide
association approach using populations that have been
phenotyped for bone mineral density (BMD) and densely
genotyped. Intriguing findings have included the vitamin D
receptor, the Sp1 binding site in COL1A1, and the estrogen
receptor ESR1.
(1) However, replication of the results among
studies has been difficult for a variety of reasons (eg, population
stratification, ethnicity, physiologic factors, and gender), and
associations have been rather low. Nevertheless, a number of
reports have shown that regions and specific genes on human
chromosome 1 (Chr 1) are associated with BMD, a widely used
marker of osteoporosis. For example, Reed and colleagues
(2,3)
found that absorptive hypercalciuria (genetic location 1q23-24)
coupled with reduced spinal BMD yielded adenylate cyclase
(ADCY10) as a candidate gene for osteoporosis. Quantitative trait
loci (QTLs) located at 1q21-24 have been reported for BMD in
lumbar spine by Koller and colleagues,
(4) as well as by Deng and
colleagues
(5) and Wilson and colleagues
(6) at 250 and 270 cM,
respectively. Recently, Ioannidis and colleagues have reported a
meta-analysis of nine genome-wide association studies limited
to women that found several chromosomal regions, including
1p13.3–1q23.3, with significant BMD association.
(7) In two
additional studies, Schaffer and colleagues
(8) found significant
association of BMD with 1q23 in young 25- to 45-year-old
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88Mexican Americans, and Ichikawa and colleagues
(9) reported a
significant association of BMD with a haplotype block containing
11 genes on 1q in premenopausal white women, but the specific
gene was not identified.
Not surprisingly, expanding discoveries in biomolecules and
their mechanisms of action affecting osteoblast or osteoclast
functions have led to examination of specific genes for roles in
osteoporosis. In a comprehensive review by Deng and
colleagues, the number of specific bone-related genes with a
plausible connection to osteoporosis is extensive, and these
genesarelocatedacrossthegenome.
(10)Examplesofsuchgenes
have been described by (1) Chen and colleagues,
(11) who
reported significant correlation of signal transducer and activator
of transcription 1 (STAT1) upregulation with low BMD in white
women, (2) Brochmann and colleagues,
(12) who found that Bone
Morphogenetic Protein 2 (BMP2) appears to be regulated by
secreted phosphoprotein 24kDa (SPP24), (3) Reppe and collea-
gues,
(13) who found eight genes, including chromosome 1 open
reading frame 61 (C1orf61), that in transiliac biopsies were
significantly associated with BMD in postmenopausal white
women, and (4) Mori and colleagues,
(14) who reported a
significant association of thrombospondin (ADAMST4) with spinal
and femoral BMD in Japanese women. Each of these four genes
is located on mouse Chr 1.
We and others have reported that the distal region of mouse
Chr 1, which shares conserved synteny with the long arm (q) of
human Chr 1, carries QTLs that regulate BMD.
(14,15) To capitalize
on the control of experimental variables and the ease of gene
mapping in mice, we developed a set of nested congenic strains
that have allowed us to test which regions on Chr 1 are
responsible for regulation of BMD.
(16) Using these nested
congenic strains, we found that the BMD5 QTL on Chr 1 consists
of three regions with sex- and site-specific bone-compartment
effects.
(14) Here we present fine mapping of one of these regions
designated QTL1. We also present additional phenotyping data
with dietary manipulation and initial expression data for two
BMD candidate genes, absent in melanoma 2 (Aim2) and
AC084073.22.
Materials and Methods
Mice
The inbred mouse strains used for the studies reported herein
were obtained from our research colonies at The Jackson
Laboratory (Bar Harbor, Maine, USA). The C57BL/6BmJ (B6/Bm)
and B6.C3H Chr 1 congenic sublines of mice were produced by
pair matings, with progeny weaned at 22 to 25 days of age and
housed in groups of 2 to 5 of the same sex in polycarbonate
cages (324cm
2) with sterilized white pine shavings. Colony
environmental conditions included 14:10-hour light/dark cycles
with free access to acidified water (pH 2.5, with HCl to retard
bacterial growth) that contains 0.4mg/mL of vitamin K
(menadioneNabisulfite)andanirradiatedNIH31dietcontaining
6% fat, 19% protein, and Ca:P of 1.15:0.85, plus vitamin and
mineral fortification (Purina Mills International, Brentwood, MO,
USA). All animal studies were approved by the Institutional
Animal Care and Use Committee of The Jackson Laboratory.
Dietary treatment
At 2 months of age, female mice were assigned to experimental
groups, with group sizes of 16 to 27 mice. Mice were fed either a
high-fat diet (42% fat, 1% cholesterol, 0.5% cholate, 20% protein,
and Ca:P ratio of 1.08:0.85; hereafter 42% fat diet) or continued
on the standard NIH 31 (6% fat) diet described earlier. Dietary
treatments were continued until mice were 4 months of age.
Consumption studies demonstrated that mice consumed
equivalent amounts of food by weight (high-fat/cholesterol/
cholate diet, 3.13g/mouse/day; NIH 31 diet, 3.22g/mouse/day).
Congenic sublines and genotyping
We previously reported B6.C3H-1 congenic strains for distal
mouse Chr 1 that carry femoral volumetric BMD (vBMD) and
trabecular microstructure regulation in female and male
mice.
(14,16) The genetic segment of interest, designated QTL1,
was mapped to D1Mit355. To fine map this genetic segment, two
new congenic sublines were developed, B6.C3H-1-12-1 (1-12-1)
and B6.C3H-1-12-2 (1-12-2), by mating B6.C3H-1-12 (1-12) N10
generation mice with B6/Bm progenitor strain mice. The N11F1
offspring were intercrossed to obtain segregating N11F2 progeny
that were genotyped to identify smaller C3H segments. These
were used to establish 1-12-1 and 1-12-2 sublines that are
homozygous for different overlapping segments of the C3H
genome on distal Chr 1. The formal nomenclature for the
congenic strains is found in the legend to Fig. 1.
Mice were genotyped by preparing genomic DNA from
digestion of 1-mm tail tips in 0.5mL of 50mM NaOH for
10minutesat958C;thenthepHwasadjustedto8.0with1MTris-
HCl. Genotyping of individual mouse DNAs was accomplished by
polymerase chain reaction (PCR) using oligonucleotide primer
pairs from several sources (Research Genetics, Birmingham, AL,
Fig. 1. Femoral pQCT vBMDfor 16-week-oldfemales from B6/Bmandsix
congenic strains covering distal chromosome 1. Congenic means that
differ from B6/Bm are indicated by asterisks. Data are means SEM
(group size n¼21 to 48). The formal designations for these inbred strains
are 1-11: B6/Bm.C3-(D1Mit111-D1Mit359)BmJ; 1-19: B6/Bm.C3-(D1Mit111-
rs6197487)BmJ; 1-16: B6/Bm.C3-(D1kls17-1-rs3654101)BmJ; 1-12: B6/
Bm.C3-(D1Mit355-D1Mit359)/BmJ; 1-12-1: B6/Bm.C3-(D1Mit355-kls2-1)/
BmJ; and 1-12-2: B6/Bm.C3-(rs31592036-D1Mit359)/BmJ.
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Qiagen, Valencia, CA, USA). These primer pairs amplify sequence-
length polymorphisms (SSLPs) consisting of CA repeat
sequences wherein the length of the repeat is strain-specific
(Mit Markers, www-genome.wi.mit.edu/cgi-bin/mouse/index).
Details of standard PCR reaction conditions have been provided
previously.
(17) PCR products from B6/Bm, C3H, and F1 hybrids
were used as electrophoretic standards in every gel to identify
the genotypes of mice (ie, b6/b6, b6/c3h, c3h/c3h). In addition to
the SSLP markers just described, five additional markers were
developed in our laboratory to further define the congenic
regions. Specifically, ‘‘novel’’ SSLPs were identified in the region
of interest, and primers were designed to amplify these regions
by PCR. Eight markers representing flanking sequences for CA
repeats were designed with the aid of Frodo.wi.mit.edu/cgi-bin/
primer3/ and MacVector. Custom primer pairs were obtained
from Invitrogen and tested against B6/Bm and C3H genomic
DNA to confirm polymorphisms (listed in Table 1). In addition, 14
single-nucleotide polymorphisms (SNPs) within the 171.1 to
179.3 region (NCBI Ensembl Build 37, Release 56) that were
assayed for the sublines are presented in this article. SNP
genotyping was performed at KBiosciences (Herts, UK;
www.KBioscience.co.uk).
Necropsy
At 16 weeks of age, when mice have acquired their adult femoral
mass,
(18) females from the B6/Bm progenitors and the newly
developed distal Chr 1 sublines were necropsied and whole-
body weights recorded. Whole-body areal BMD (aBMD) and
body-composition data were collected by PIXImus (DEXA; GE-
Lunar, Madison, WI, USA) densitometry, as described below.
Skeletal preparations (lumbar vertebral columns, pelvis, and
attached hind limbs) were placed in 95% ethanol (EtOH) for a
periodofnotlessthan2weeks.Lumbarvertebralcolumns,tibias,
and femurs were dissected free of remaining muscle and
connective tissue and placed in 95% EtOH for storage. vBMD was
assessed by peripheral quantitative computed tomography
(pQCT) as described below.
Ovariectomy
Four-month-old B6/Bm and congenic strain mice were treated
by sham surgery or ovariectomy under isofluorane anesthesia
and aseptic conditions. Postoperatively, the mice were main-
tained under standard dietary (NIH 31 diet) and environmental
conditions for 6 weeks. Necropsies were performed and whole-
body densitometry data obtained by PIXImus (procedure
described below).
X-ray densitometry
PIXImus for aBMD
Female mice were measured at necropsy for whole-body aBMD
and percent body fat using the PIXImus dual-energy X-ray
absorptiometer (GE-Lunar). The PIXImus was calibrated daily
withamousephantomprovidedbythemanufacturer.Micewere
placed ventral side down with each limb and tail positioned
away from the body. Full-body scans were obtained and X-ray
absorptiometry data gathered and processed with manufac-
turer-supplied software (Lunar PIXImus 2, Version 2.1, GE-Lunar).
The head was specifically excluded from all analyses owing to
concentrated mineral in skull and teeth.
pQCT for vBMD bone densitometry
vBMD was measured on the left femur of female B6/Bm and
congenic subline mice, as described previously.
(14) Briefly,
isolated femur lengths were measured with digital calipers
Table 1. Primer Sequences
Gene Forward primer Reverse primer
AC084073.22 TGTACACAAAGAGCAGGAC CTCACAGTACAGTTTGGTAAATTG
Aim2 CACCCTCATGGACCTACACTA CGTTGTTAGTAAATCAGCAGTTCT
Primer name
kls27-3 TTTATTGAGGAAATTGACAGAA GTGTCATGGGAAGTTTCATT
kls17-1 AAGGGGGTTCTACCTATCAG CTTCCCATTTGACCACTAAA
kls5-1 GAATATGGAATCTGACTGTGG ATGAAAACCTGATCTTGGTG
rs30595455 ATTTGTGGTTCCAGGCAACATC GGGACTCGGGACTTTTTGAATG
rs30707811 AGGACATTATTAGCAACTCGCCC AGATTCACCTGCCCTACTTTACTCC
kls8-4 TCAAGCCTCAACTAAAGGTC GTTTTGCCTTGTGTTTCTTC
rs3718078 GATGTCCTTGGGGTTCAAATGAC TGCTATCAGGCTCGCTTAGTTCAG
rs31606438 TGCTGGGTTCATTTCAAAGGTC ATGGGGTAGGGTAGTTATGTCGG
rs6197487 TCTCAGGTTATTTTCAGGCTTG AAGAGTCCCAGACACTTCTCCCTC
rs31335968 ATTTCTGTAGGCTCCAGGGGTGTC TAGGGTAGTTATTGCGGGGACG
rs31592036 TATCCCCCTGTGACTTGCTGAC TACCCTCCAGTGAATGCTGCCTTC
kls4-6 AGTCAGCACCACTGTCATTT TGGCTTTGTACCAATACCAT
kls9-2 TCCATGGAGTGAGTCTAACC TCTTCTACAGGGCAGGACTA
kls4-5 GTTCTGCTCCATCTTCCTTT GAAGGATTGGAATTTTGACA
rs3699295 TCCATAACTCCAGACACCTTTGC AACCCATAGCCAGCCCAGATACTG
kls2-1 GGCTTGGATAATGATGAATG CCATCCATCTCTCCACTTAG
rs3655994 TGCCATGAATTACCACAATCCC GCAGCATAGCTTCGCTGTTTG
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density using the SA Plus densitometer (Orthometrics, White
Plains, NY, USA). Calibration of the SA Plus instrument was
accomplished with a manufacturer-supplied phantom. The bone
scans were analyzed with Orthometrics software Version 5.50.
Mineral content was determined with thresholds such that
mineral from most partial voxels (0.07mm) would be included in
the analysis. Isolated femurs were scanned at seven locations at
2-mm intervals beginning 0.8mm from the distal ends of the
epiphyseal condyles. Given the variation in femur lengths, the
femoral head could not be scanned at the same location for each
bone and thus was not included in the final data. Total vBMD
values were calculated by dividing the total mineral content by
thetotalbonevolumeandexpressingtheresultinmilligramsper
square millimeter. Cortical thickness was obtained at the
midshaft scan.
mCT40 for distal trabecular bone
Trabecular bone components of the distal femur were measured
by mCT (MicroCT40, Scanco Medical AG, Bassersdorf, Switzer-
land) as described previously.
(14) The MicroCT40 unit was
calibrated weekly with a phantom standard provided by Scanco.
The femurs were scanned at the energy level of 55KeV and
intensity of 177mA, followed by analysis of the trabecular bone
(BV) with Scanco software Version 5.0. Approximately 150 cross-
sectional slices were made at 12-mm intervals at the distal end.
Beginning at the edge of the growth plate and extending in a
proximal direction, 100 contiguous slices were selected for
analysis.
Quantitative Real-Time PCR
RNA was extracted from femurs of four 10-week-old congenic
and B6/Bm female mice fed the respective diets for 2 weeks.
Femurs were isolated and snap frozen in liquid nitrogen, RNA
then was isolated using the Total RNA Isolation System
(Promega, Madison, WI, USA) as per the manufacturer’s
instructions. DNA was removed using DNase treatment and
removalreagents(Ambion,Inc.,Austin,TX,USA).RNAqualityand
quantity were assessed using an Agilent Bioanalyzer (Caliper
Technologies Corp., Hopkinton, MA, USA). Then 400ng of RNA
was converted to cDNA in a Real-Time (RT) reaction using the
MessageSensor RT Kit (Ambion, Inc.) and random decamers as
primers. The RT-PCR primers for Aim2 and AC084073.22 were
designed and purchased from PrimerDesign Ltd. (Southampton,
UK). The cDNA then was diluted 1:10 with water. For each PCR
reaction, 2.5mL of diluted cDNA was added to 5mL of Power
SYBR Green Master Mix (Applied Biosystems, Foster City, CA,
USA) and 100 nM of each forward and reverse primer and 1.5mL
of H2O in a total reaction volume of 10mL. Cycling conditions
were a hold of 2minutes at 508C, a hold of 10minutes at 958C,
and 40 cycles at 958C for 15seconds and 608C for 1 minute, and
all reactions were run on the ABI 7500 Sequence Detection
System(AppliedBiosystems).ExpressionofAimandAC084073.22
wasassessedbycomparingtheexpressionofeachwithanaverage
of the housekeeping genes Gadph and B2M using the DDCt
method.
(19) Probe efficiencies were optimized by Primer Design
(http://primerdesign.co.uk/research_with_integrity.html). Each
experiment was run in triplicate with different cDNA preps
fromthesamemice.PrimersequencesforAim2andAC084073.22
are reported in Table 1.
Primary calvarial osteoblast cultures
Calvarial osteoblasts were isolated using a modified method
from Wong and Cohn.
(20) Calvaria were dissected from neonatal
mice (1 to 3 days of age) and maintained in sterile phosphate-
bufferedsaline (PBS)until the dissection wascompleted. Calvaria
were subjected to four sequential 15-minute digestions in an
enzymesolutioncontaining0.05% trypsin(Invitrogen)and3.6U/
mL of collagenase P (Roche Diagnostics, Indianapolis, IN, USA) at
378C on a rocker platform. Cell digestion fractions 2 to 4 were
collected and chilled by the addition ofcold Dulbecco’s Modified
Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS),
100 U/mL ofpenicillin, and 100mg/mL of streptomycin. Fractions
were pooled, centrifuged, and resuspended in DMEM with 10%
FBS. Cells were plated at a density of 1.5 10
4 cells/cm
2 in 35-
mm dishes. After 7 days of culture, some dishes were changed to
differentiation medium (a-MEM, 10% FBS, 50mg/mL ascorbic
acid, and 8mM b-glycerophosphate), whereas other cultures
were stained for alkaline phosphatase. On day 18 of culture,
remaining dishes were stained with alizarin red for calcium
deposits.
Alzarin red–stained wells were imaged using a Leica Wild M10
stereomicrocsope and a Leica DFC 300 FX cooled CCD (Wetzlar,
Germany). Images were processed using ImageJ imaging
software (rsbweb.nih.gov/ij/). Specifically, a threshold was
established to remove background staining, applied to each
0.5  image, and then the number of pixels corresponding to
alzarin red–stained areas (histogram intensity of 0 to 80) was
determined. Total alzarin red
þ pixels from these images (one
image per 35-mm culture well) representing six independent
cultures were averaged for B6/Bm and 1-12 congenics.
Histomorphometry
Groups of B6/Bm and 1-12 congenic females were dual labeled
for bone histomorphometric analyses. Mice were injected with
20mg/kg of calcein (intraperitoneal) at 15 weeks and 50mg/kg
of demeclocycline 7 days later. Mice were necropsied 48hours
following the demeclocycline injection. Femurs were dissected
free of muscle and fixed in 10% NBF at 48C, then stored in 70%
EtOH at room temperature. The femur samples were embedded
undecalcified in methyl methacrylate. Longitudinal sections
5mm thick were cut on a Micron microtome (Micron, Richard-
Allan Scientific, Kalmazoo, MI, USA) and stained with 0.1%
toluidine blue (pH 6.4). Static parameters of bone formation and
resorption were measured in a defined area between 360 and
1440mm from the growth plate using an Osteomeasure
Morphometry System (Osteometrics, Atlanta, GA, USA). For
dynamic histomorphometry, mineralizing surface per bone
surface and mineral apposition rate were measured in unstained
sections under ultraviolet light, as described previously.
(21) Bone-
formation rate was calculated. The terminology and units used
are those recommended by the Histomorphometry Nomencla-
ture Committee of the American Society for Bone and Mineral
Research.
(22)
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Statistical evaluation was undertaken using JMP Version 7.0 (SAS,
Inc., Cary, NC, USA). For the pQCT and mCT data, any body size
differences between strains were accounted for by using body
weight and femur length as covariates when they contributed
significantly to an overall ANCOVA model.
(23) Data are expressed
as adjusted least squares mean SEM in all figures. Differences
between means for B6/Bm and each congenic subline were
tested by Student’s t test, with significance declared when a
p .05 was observed.
Results
The phenotypic femoral vBMD data obtained from 4-month-old
B6/Bm progenitor and congenic strain females are presented in
Fig. 1. Congenics B6.C3H-1-11. B6.C3H-1-19, B6.C3H-1-16, and
B6.C3H-1-12 (hereafter 1-12) all have significantly greater vBMD
values than B6/Bm, as reported previously.
(14) To further refine
the Chr 1 critical region, two new strains, 1-12-1 and 1-12-2, were
developed from 1-12. vBMD in 1-12-1 is significantly increased
compared with B6/Bm, whereas vBMD in 1-12-2 is not different
from that in B6/Bm. The congenic strains that demonstrate
increased vBMD all have C3H alleles for the shared critical
0.152Mb critical region located between markers kls5-1 and
rs6197487, whereas the 1-12-2 congenic, which does not have
increased femoral vBMD, has B6/Bm alleles in this critical region
(Fig. 2).
Distal femurs from female B6/Bm progenitor and 1-12 con-
genic mice were examined by histomorphometry for evidence
of increased bone formation. The data in Table 2 showed that
in comparison with B6/Bm bones, the 1-12 congenic bones had
(1) significantly increased bone volume owing to an increase
in trabecular thickness, (2) an unchanged trabecular number,
(3) an increased mineralizing surface, and (4) an increased
bone-formation rate. These data are consistent with our previous
observations of the B6.C3H-1-11 strain, the progenitor of the 1-
12 strain.
(14) The histomorphometric data did not reveal
differences in the number of osteoblasts, osteoclasts, or eroded
surface/bone surface (latter data not shown).
Of the two congenic strains carrying smaller C3H genomic
segments from 1-12, 1-12-1, but not 1-12-2, showed increased
femoral vBMD with respect to B6/Bm. To determine whether
changes in vBMD are a consequence of changes in total mineral
or in total volume, femurs from B6/Bm, 1-12, 1-12-1, and 1-12-2
females were examined by pQCT. The pQCT data in Fig. 3
showed that the greater vBMD correlated with increased mineral
content. Interestingly, all three congenic strains showed
increased femoral volume compared with B6/Bm.
Whole-body densitometry by PIXImus was employed to
determine whether the increased vBMD and mineral content
observed in the femur were detectable in the entire skeleton.
Figure 4 presents the aBMD, bone mineral content (BMC),
percent body fat, and total tissue mass for B6/Bm, 1-12, 1-12-1,
and 1-12-2 congenic strain females. The aBMD and BMC in 1-12
and 1-12-1 mice were significantly greater than in either B6/Bm
or 1-12-2 mice. The percent body fat and total tissue mass of all
three congenic strains were significantly greater than in the B6/
Bm progenitor strain. No differences were found in total-bone
area of any strain (data not presented).
Microstructural properties of trabecular bone in the distal
femurs of B6/Bm, 1-12, 1-12-1, and 1-12-2 strains were assessed
by mCT (Fig. 5). The 1-12 and 1-12-1 congenics had significantly
increased bone volume fraction (BV/TV) and trabecular thickness
compared with either B6/Bm or 1-12-2 femurs. Trabecular
number did not differ among strains.
To gain insight into the biology underlying the differences in
mineral content and vBMD observed between the congenic
lines, we established primary cultures of neonatal calvarial
osteoblasts from 1-12 and B6/Bm mice (Fig. 6). The alizarin red
staining of cultures indicated that there was 4.4-fold increase in
mineralized nodule area in 1-12 osteoblasts on day 18 compared
with B6/Bm osteoblasts, suggesting that osteoblast progenitors
and activity are greater than observed for B6/Bm mice.
Bone density responses to ovariectomy or dietary fat
The B6/Bm and congenic strains were tested for their skeletal
responses to regulatory challenges in the form of gonadectomy
and dietary fat manipulation. Loss of ovarian steroid for 6 weeks
resulted in all strains losing significant amounts of aBMD, as
shown in Fig. 7. The aBMD data presented in Fig. 7 showed that
1-12 and 1-12-2 strains lost significant aBMD, whereas the B6/Bm
and 1-12-1 mice did not have significant bone loss.
Fig. 2. Genetic haplotype map of distal chromosome 1 for six congenic
sublines. Physical locations, genetic markers, and selected genes are
given for each subline, along with diagrammatic presentation of the
alleles in the chromosomal region represented in the sublines. The
rectangle to the right of the diagram indicates the critical region contain-
ing the vBMD regulation.
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According to the current mouse genome assembly (Ensembl
Release 58, May 2010, www.ensembl.org), the 0.152-Mb
critical region defined by our nested congenic strains
contains two known genes, absent in melanoma 2 (Aim2,
ENSMUSG00000037860)andaputativeproteincodingsequence
listed in the Ensembl mouse genome assembly as AC084073.22
(ENSMUSG00000037849). We examined the expression of these
two genes in 1-12-1 and 1-12-2 mice by quantitative real-time
PCR (qRT-PCR) analysis of whole-bone cDNA to determine if
genotype differences existed. The expression data for congenic
strain female mice at 10 weeks of age are presented in Table 3.
The results showed that both 1-12-1 and 1-12-2 female mice
expressed higher amounts of Aim2 than similarly aged B6/Bm
female progenitor mice on the standard 6% fat NIH 31 diet.
On the other hand, comparison of expression for AC084073.22
in 1-12-1 and 1-12-2 female mice treated with the 6% fat NIH 31
diet showed genotype differences. The 1-12-1 bone showed
significantly less whereas 1-12-2 showed significantly more
expression of AC084073.22 than B6/Bm bone.
Discussion
Fine mapping and candidate gene analysis
Using new congenic sublines, we confirmed the female vBMD
regulation associated with the D1Mit355 region, as originally
reported.
(14) The two new congenic sublines, 1-12-1 and 1-12-2,
yield a smaller genetic segment amenable for molecular and
functional studies of candidate genes. Use of flanking markers
(kls5-1 to rs6197487) established the maximum size of the critical
region to be 0.174 Mb. Current mouse genome annotation
(Ensembl, Version 55) predicts only two genes in this region,
Aim2 and AC084073.22. These genes are members of the P200
cluster of interferon-activated genes
(24) that now consists of 9
loci (www.ensembl.org/Mus). Meiotic recombination yielded
congenic strain 1-12-1, which contains C3H sequences for Aim2,
AC084073.22, and BC094916, whereas congenic strain 1-12-2
contains C3H sequences for Pyhin1, Ifi204, Ifi203, Mnda, Ifi202a,
and Ifi205. The BC094916 gene has been eliminated from the
critical region by the increased BMD phenotype of the B6.C3H-1-
19 strain, which does not carry the C3H allele for BC094916.
The mouse and human P200 cluster of interferon-activated
genes is located on mouse distal Chr 1 (between 94.0 and 95.4
cM) and on human Chr 1 (between 1q21 and 23). The mouse
region has approximately 9 paralogous genes (Aim2, AC084073,
BC094916, Pyhrin1, Ifi204, Ifi 203, Mnda, Ifi202b, and Ifi205),
whereas the homologous human Chr 1 region has 4 paralogues
(Aim2, Pyrin1, Ifi16 (Ifi205), and MNDA). In both species, these
genes are sufficiently similar in structure to have arisen from
duplication events and are involved with cell growth and
differentiation. Collectively, the proteins derived from these
genes carry all or part of the PAAD/DAPIN/pyrin domains though
to be involved in apoptotic and inflammatory signaling
(reviewed in ref. 24).
Functions have been described for several of the genes in
mice, with Ifi202 and Ifi204 of particular interest for bone biology
because they have been shown to support chondrogenic and
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MOUSE DISTAL CHR 1 BMD CANDIDATE GENES Journal of Bone and Mineral Research 93Fig. 3. Femoral pQCT data for B6/Bm progenitor, 1-12, 1-12-1, and 1-12-2 congenic strain females at 16 weeks of age. Significant differences compared
with B6/Bm mice are indicated by asterisks. Data are means SEM (group size n¼36 to 48).
Fig. 4. Whole-bodydatafor B6/Bmprogenitor,1-12,1-12-1, and1-12-2congenicstrainfemalesat 16 weeksofage.Significantdifferencescomparedwith
B6/Bm mice are indicated by asterisks. Data are means SEM (group size n¼19 to 21).
94 Journal of Bone and Mineral Research BEAMER ET AL.Fig. 5. mCT data from distal femurs of 1-12, 1-12-1, and 1-12-2 congenic strain females at 16 weeks of age. Significant differences among strains are
indicated by asterisks. Data are means SEM (group size n ¼19 to 20).
Fig. 6. B6/Bm progenitor and 1-12 neonatal calvarial osteoblasts on day 18 of culture stained for alizarin red. Digitized images (2300 1700mm) from 6
wells per genotype were used to quantify the alizarin red–stained nodules.
MOUSE DISTAL CHR 1 BMD CANDIDATE GENES Journal of Bone and Mineral Research 95osteogenic differentiation, respectively.
(25,26) Aim2 was thought
originally to be a tumor-suppressor gene associated with human
melanoma
(27) and breast cancer cells.
(28) More recently, Aim2 has
been considered to be a protein that recognizes and binds to
cytosolic dsDNA, forming a capase-1-activating complex that
leads to apoptosis of the cell.
(29) Aim 2 has 12 exons that encode
for a protein of 354 aa. AC084073 does not yet appear to have an
identified counterpart in the human P200 cluster. The homo-
logue may not have been discovered yet, or the mouse P200
cluster may have undergone considerably more gene duplica-
tionthanthatofthehuman.AC084073has3exonsandpredicted
protein of 150 aa (www.ensembl.org). Its function remains to be
described.
Aim2
The complete genomic sequence for the B6/Bm allele of Aim2 is
available from the NCBI m37 mouse assembly. The complete
genomicsequencefortheC3HalleleofAim2isavailablefromthe
Sanger mouse genomes project (www.sanger.ac.uk/modelorgs/
mousegenomes/).ThereisoneSNPinexon2(rs31606638)ofC3H
that is synonymous to B6/Bm, and there are at least 14 SNPs in
the 3’ UTR. All the SNPs in the 3’ UTR potentially could influence
transcript stability or translation. Binding of miRNAs or RNA-
binding proteins to target sequences in 3’ UTRs has been shown
to influence translation.
(30) For example, Wang and colleagues
showed that a risk-conferring polymorphism for Parkinson
diseaseinhumanpopulationsresidesinthe3’UTRforFGF20.The
polymorphism is in a binding site for miRNA-433 and increases
translation of FGF20 both in vitro and in vivo. We used
TargetScanMouse
(31) to scan the Aim2 3’ UTR for miRNA binding
sites, compared these sites with the positions of the 3’-UTR SNPs,
and found that three of the 3’-UTR SNPs reside in miRNA target
sites. One, rs47500792, is in a putative binding site for mmu-
miR335-3p, and the other two, rs47154027 and rs46439487, are
adjacent SNPs that are in a putative binding site for mmu-
miR370. These potentially could influence the translation of
Aim2; therefore, future work will be directed at testing the
influence of these SNPs on Aim2 translation.
Aim2 is expressed in bone marrow and mature B cells,
(32)
which places expression in the area of the bone niche where
preosteoblasts and preosteoclasts reside. Aim2 has a demon-
strated role in apoptosis by binding cytoplasmic dsDNA
fragments.
(29,33) When Aim2 was tested by RT-PCR, we found
that compared with B6/Bm progenitors, there was significant
upregulation in both 1-12-1 and 1-12-2 mice fed the 6% fat NIH
31 diet compared with similarly treated B6/Bm controls. The 42%
fat diet suppressed these expression differences in both strains.
Thewhole-bodyPIXImusBMDmeasurementof1-12-2,butnot1-
12-1, mice was reduced by the 42% fat diet. Since 1-12-1 and 1-
12-2 congenics carry different alleles for Aim2 and have different
constitutive BMD values, the similarity of expression level under
control and experimental conditions would suggest that
differential regulation of Aim2 is not likely to be involved in
BMD regulation.
AC084073.22
The complete genomic sequence for the B6/Bm allele of
AC084073.22 is available from Ensembl Release 58. In addition,
the complete genomic sequence for the C3H allele of
AC084073.22 is available from the Sanger Mouse Genomes
project (www.sanger.ac.uk/modelorgs/mousegenomes/). In
these data, there are 73 SNPs in the AC084073.22 genomic
region (which includes both introns and exons), and among
Fig. 7. Whole-body data for B6/Bm, 1-12, 1-12-1, and 1-12-2 congenic strains 6 weeks after ovariectomy or after 8 weeks of treatment with 6% fat NIH 31
diet or 42% fat diet. Significant treatment-induced differences within strains are indicated by asterisks. Data are means SEM (group size n¼16 to 27).
Table 3. Expression of Aim2 and AC084073.22 in Whole Femurs
From Females
Strain Gene Fold change p Value
B6.C3H-1-12-1 Aim2 2.11 .007
B6.C3H-1-12-2 Aim2 1.78 .005
B6.C3H-1-12-1 AC084073.22 0.55 .028
B6.C3H-1-12-2 AC084073.22 1.92 .049
Note: Fold change determined from comparison with B6/Bm controls.
96 Journal of Bone and Mineral Research BEAMER ET AL.these, there are three coding SNPs and one splice-site SNP. One
of the three exonic SNPs is a nonsynonymous coding SNP. This is
a known SNP (rs31605595) that results in an asparagine
substitution for lysine in the coded protein. The other 2 exonic
SNPs are in the 3’ UTR, and using TargetScanMouse,
(31) we found
that neither of these SNPs overlaps with known miRNA binding
sites. The splice-site SNP is also known (rs31605596) and resides
in the 5’ splice donor site of intron 1. In this case, the C3H variant
maintainsthe consensus splice donor sequence (GUPuAGU), and
the B6/Bm allele is nonconsensus (GUPuAGC). We found that
compared with B6/Bm mice on the 6% fat NIH 31 diet,
AC084073.22expression inbonewassignificantly decreased in1-
12-1 mice (which contain the C3H allele) but significantly
increased in 1-12-2 mice (which contain the B6/Bm allele). The
prediction based on these data is that alternative splicing of the
B6/Bm allele could lead to upregulation of AC084073.22. On the
other hand, the substitution of a lysine for an asparagine could
have a deleterious impact on protein function. We used a tool
available from the Panther database (www.pantherdb.org/tools/
csnpScore.do) to calculate a subPSEC score based on an
evolutionary analysis of this coding SNP.
(34) The calculated
subPSEC score was –1.6, which corresponds to an approximately
19% probability of being deleterious. Based on these data, we
predict that the splice-site SNP is more likely to contribute to
differential function of this gene in B6/Bm and C3H. More
detailed analysis is needed to determine whether the non-
canonical splice site in B6/Bm leads to a strain-specific transcript
isoform and/or whether aberrant splicing underlies the
differential expression we observed by quantitative RT-PCR.
However, our data show that differential expression of this gene,
and not Aim2, is correlated with the bone density phenotypes
described herein. Therefore, we hypothesize that AC084073.22
underlies the bone density regulation in females that we have
mapped to distal Chr 1.
Dietary fat and distal Chr 1 BMD regulation
By using a B6C3F2 cross and a 6% fat NIH 31 diet, we originally
found that a region on distal Chr 1 increased BMD.
(14) On the
otherhand, Farber and colleagues
(35) did notobserve a distalChr
1 BMD QTL in B6C3F2 mice fed a 42% fat diet. Our congenic
strainanalyses identifieda0.152-Mb regionofC3Hsequenceson
distal Chr 1 shared by 1-12 and 1-12-1 strains that consistently
influenced BMD. We hypothesized that the 42% fat diet would
reduce the BMD phenotype associated with the 0.152-Mb region
identified in our congenic mice. In fact, the aBMD value of the 1-
12-1 congenic strain was not reduced by the 42% fat diet,
whereas the aBMD values of the 1-12 and 1-12-2 strains were
reduced by 42% fat diet. These data suggest that the genomic
regionsharedby the 1-12and 1-12-2 strains, butnot bythe 1-12-
1 strain, carries a dietary fat-responsive locus that is different
from the region shared by the 1-12 and 1-12-1 strains that
regulates BMD. Although the hypothesis about dietary regula-
tion of BMD in distal Chr 1 appears tenable, the actual candidate
regionfordietaryactionappearstoresideinthe3.007-Mbregion
between kls2-1 (176.297 Mb) and rs3668273 (179.304 Mb).
The distal region of Chr 1 has a growing list of genes linked to
bone regulation. For example, the Darc gene has been identified
previously as regulating BMD in B6.CAST-1 congenic mice.
(36)
Darc is located at 175.262 Mb, which lies proximal and outside
the C3H sequence found in 1-12 mice. A second gene is Ifi204,
with a known role in osteoblasts. Specifically, the Ifi204 protein is
partofaregulatory transcriptional complexand servesas alinker
between Rb and Cbfa1 proteins, leading to expression of
osteocalcin and alkaline phosphatase genes.
(37) This gene lies
within the 1.272-Mb region of the C3H sequence shared by 1-12-
1 and 1-12-2 strains. As noted earlier, Ifi202 has been reported
recentlytohavearoleinchondrogenesis.
(25)Theregionof1-12-2
mice that does not overlap with 1-12-1 mice contains about 78
genes that could be targets for high-fat-diet regulation. One of
these genes is Grem2, whose expression was reported in fat by
Farber and colleagues to be highly correlated with BMD in their
B6C3F2 mice. We did not find an effect of diet on Grem2
expression in bone for either 1-12-1 or 1-12-2 mice compared
withB6/Bm mice(data notpresented). Grem2 hasbeen shown to
be an inhibitor of osteoblast differentiation through suppression
of bone morphogenetic protein 2 (BMP-2) action, and its
suppression promotes osteogenesis in vitro.
(38) Our data suggest
that AC084073.22 is a fifth gene on distal Chr 1 with bone
regulatory action.
There are several limitations to our study. First, the data
reported herein apply only to female mice from these congenic
strains.Second,westilldonotknowwhichpolymorphicregionis
responsible for differences in AC084073.22 expression, nor the
precise mechanism responsible for changing the magnitude or
direction of transcript expression. The AC084073.22 protein
levels are not yet measureable to assess observed genotypic
effects between 1-12-1 and 1-12-2 strains in any tissue. Third, we
cannot exclude the possibility that there is a cell-autonomous
defect in osteoclasts in 12-1 mice even though by histomor-
phometry ES/BS and number of osteoclasts per bone surface
of 1-12 did not differ from B6/Bm. The absence of bone loss in 1-
12-1 mice in response to a high-fat diet and the greater
trabecularthickness bymCTofthis sublinecould bedueinpartto
impaired osteoclast activation or differentiation. Challenge
studies with parathyroid hormone (PTH) could help to determine
if the higher bone mass in the 1-12-1 congenic strain is due
to increased bone formation alone or a combination of
reduced bone resorption and increased formation. Finally, the
AC084073.22 gene is reported to be a member of the interferon
(IFN)–activated P200 gene cluster based on its genetic sequence.
At this time, there are no data demonstrating that either IFN-a
or IFN-b change AC084073.22 expression. Hence the relationship
of AC084073.22 to these cytokines remains to be determined.
Nonetheless, our mapping and gene-expression data suggest
that AC084073.22 is a strong candidate gene for a bone
regulatory QTL on distal Chr 1 that underlies BMD differences
between B6/Bm and C3H mice. Understanding the mechanism
of action of this gene and its relationship to cells in the
bone remodeling unit will be important steps in our discovery
process.
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